Literature DB >> 7021573

A modified technique for the detection of hepatitis B virus-specific DNA polymerase.

C T Fang, N Nath, M Pielech, R Y Dodd.   

Abstract

A modified and improved technique for the detection of hepatitis B virus-specific DNA polymerase activity is described. DNA polymerase is released from Dane particles by mixing samples with the detergent Nonidet P-40 and beta-mercaptoethanol. After incubation of pretreated samples with a reaction mixture containing tritiated thymidine-methyl-5'-triphosphate (3H-TTP), DNA is precipitated onto a trichloroacetic acid (TCA)-treated paper. Unincorporated 3H-TTP is then chromatographically eluted with a 5% TCA solution and precipitated counts are determined. A sample is considered positive for DNA polymerase if the incorporated counts are significantly higher than the counts of a group of negative control samples. The modifications include pretreatment of the paper with TCA, chromatographic elution of unincorporated 3H-TTP with TCA solution, prefiltration of the sample through bacteriological filters, and use of sound statistical methods for evaluation of data. These changes have led to a highly reproducible, reliable and sensitive technique. The coefficient of variation of negative control samples from various test runs was in the range of 2.7-8.5%. A linear relationship between incorporated counts and DNA polymerase concentration was shown. A total of 419 serum samples from asymptomatic HBsAg-carrying blood donors were tested. Twenty-three (5.5%) of these were found to contain detectable DNA polymerase activity. All 23 samples also contained HBeAg.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021573     DOI: 10.1016/0166-0934(81)90058-6

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  Rapid method for the concentration of hepatitis B virus particles using Beckman airfuge.

Authors:  H M Milborrow; L Burnett; S B Lowe; B N Nightingale; Y E Cossart
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

2.  Significance of anti-pre-S antibodies in patients with fulminant hepatic failure.

Authors:  M Irshad; B M Gandhi; S K Acharya; Y K Joshi; B N Tandon
Journal:  Gastroenterol Jpn       Date:  1990-08

3.  Hepatitis B virus replication in patients with chronic liver diseases.

Authors:  B M Gandhi; M Irshad; S K Acharya; Y K Joshi; B N Tandon
Journal:  Gastroenterol Jpn       Date:  1990-04

4.  Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

Authors:  M G Anderson; T J Harrison; G Alexander; A J Zuckerman; I M Murray-Lyon
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.